top of page
DrugCard

DrugCard

Unclaimed profile

average rating is 3 out of 5, based on 150 votes, Ratings

#

AI-powered pharmacovigilance automation for global and local literature monitoring and regulatory intelligence.

AI Categories:

x

Pricing Model:

Contact for Pricing

Follow:

Latest Updates

Similar tools

Similar tools count
ChatOn

0

average rating is 3 out of 5, based on 150 votes, Ratings

ChatOn

Freemium

#

Revolutionize writing and creativity with AI: text-to-image, PDF mastery, voice transcription.

Seeker

0

average rating is 3 out of 5, based on 150 votes, Ratings

Seeker

Freemium

#

Enhance decision-making with secure, AI-driven data analysis and content generation.

SpinDoc

0

average rating is 3 out of 5, based on 150 votes, Ratings

SpinDoc

Contact for Pricing

#

AI-powered tool for querying and managing technical documents.

Dante AI

0

average rating is 3 out of 5, based on 150 votes, Ratings

Dante AI

Freemium

#

Unlock creativity and efficiency: AI-driven content, data analysis, customizable workflows.

Comments

Share Your ThoughtsBe the first to write a comment.

About DrugCard

Overview of DrugCard

DrugCard is an Estonian technology company specializing in pharmacovigilance automation. The company develops an AI-powered platform for automated medical literature screening, regulatory intelligence, and drug safety monitoring. DrugCard covers 121+ countries and monitors over 2,200 local journals not indexed in global databases such as PubMed, reducing literature screening time by up to 70% compared to manual processes. The platform serves pharmaceutical companies, contract research organizations (CROs), and marketing authorization holders (MAHs). In addition to its software, DrugCard offers managed pharmacovigilance services including local and global literature screening, case processing, signal detection, and regulatory writing. Founded in 2021 and headquartered in Tallinn, Estonia, the company has grown to 30 employees and serves clients across Europe, the Middle East, and Asia.

Key Features

About the tool

I'm a paragraph. Click here to add your own text and edit me. It's easy.

bottom of page